摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

17-vinyl testosterone | 1235-98-9

中文名称
——
中文别名
——
英文名称
17-vinyl testosterone
英文别名
17α-Vinylandrost-4-en-17β-ol-3-on;17-Vinyl-testosteron;(10R,13S,17R)-17-ethenyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
17-vinyl testosterone化学式
CAS
1235-98-9;4244-02-4
化学式
C21H30O2
mdl
——
分子量
314.468
InChiKey
ILGPJZIKYMIGMU-AYUYWISESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    23
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.76
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:468c6776d9dfdc8cc1c5d60f6b11d461
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    ethisterone 在 palladium, 5% on calcium carbonate, poisoned with lead 1-己烯氢气 作用下, 以 甲醇 为溶剂, 40.0~60.0 ℃ 、172.37 kPa 条件下, 反应 5.5h, 以96.7%的产率得到17-vinyl testosterone
    参考文献:
    名称:
    [EN] STEROID SPIROLACTONIZATION
    [FR] SPIROLACTONISATION DE STEROIDES
    摘要:
    公开号:
    WO2004085458A3
点击查看最新优质反应信息

文献信息

  • "METHODS AND PRODUCTS FOR TREATMENT OF DISEASES"
    申请人:Bar-Or David
    公开号:US20070111972A1
    公开(公告)日:2007-05-17
    The present invention relates to the treatment of diseases and conditions with an effective amount of a steroid having those formulas given in the specification, or a pharmacologically-acceptable salt or ester thereof. The disease or conditions treatable according to the invention include angiogenic diseases and conditions of the eye, angiogenic diseases and conditions of the brain, inflammatory diseases and conditions of the eye, inflammatory diseases and conditions of the brain and neurodegenerative diseases.
  • METHODS AND PRODUCTS FOR TREATMENT OF DISEASES
    申请人:Bar-Or David
    公开号:US20110171306A1
    公开(公告)日:2011-07-14
    The present invention relates to the treatment of diseases and conditions with an effective amount of a steroid having those formulas given in the specification, or a pharmacologically-acceptable salt or ester thereof. The disease or conditions treatable according to the invention include angiogenic diseases and conditions of the eye, angiogenic diseases and conditions of the brain, inflammatory diseases and conditions of the eye, inflammatory diseases and conditions of the brain and neurodegenerative diseases.
  • [EN] STEROID SPIROLACTONIZATION<br/>[FR] SPIROLACTONISATION DE STEROIDES
    申请人:PHARMACIA CORP
    公开号:WO2004085458A3
    公开(公告)日:2006-03-16
查看更多